$AMLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMYLIN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMYLIN PHARMACEUTICALS INC. Get notifications about new insider transactions in AMYLIN PHARMACEUTICALS INC for free.
Page: < prev 1 ... 8 9 10 11 12 13 14 15 16 ... 18 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 11 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRYSON VAUGHN D | Director | Option Exercise | A | 0.00 | 228 | 0 | 5,139 | |
| Oct 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 11.13 | 1,000 | 11,125 | 8,313 | |
| Oct 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 5.73 | 1,000 | 5,730 | 16,273 | |
| Oct 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 45.00 | 1,000 | 45,000 | 14,989 | 16 K to 15 K (-6.25 %) |
| Oct 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 11.13 | 1,000 | 11,125 | 15,989 | 15 K to 16 K (+6.67 %) |
| Oct 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 45.00 | 1,000 | 45,000 | 14,989 | 16 K to 15 K (-6.25 %) |
| Oct 10 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 5.73 | 1,000 | 5,730 | 15,989 | 15 K to 16 K (+6.67 %) |
| Oct 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief O ... | Sell | S | 42.50 | 3,000 | 127,500 | 7,996 | 11 K to 8 K (-27.28 %) |
| Oct 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 43.65 | 10,000 | 436,462 | 870,206 | 880.2 K to 870.2 K (-1.14 %) |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.73 | 2,000 | 11,460 | 5,000 | |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 43.07 | 2,000 | 86,148 | 19,956 | 22 K to 20 K (-9.11 %) |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.73 | 2,000 | 11,460 | 21,956 | 20 K to 22 K (+10.02 %) |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 12.00 | 5,000 | 60,000 | 2,907 | |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 43.57 | 5,000 | 217,847 | 118,450 | 123.5 K to 118.5 K (-4.05 %) |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 12.00 | 5,000 | 60,000 | 123,450 | 118.5 K to 123.5 K (+4.22 %) |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 5.73 | 2,000 | 11,460 | 17,273 | |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 43.67 | 2,000 | 87,347 | 14,989 | 17 K to 15 K (-11.77 %) |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 5.73 | 2,000 | 11,460 | 16,989 | 15 K to 17 K (+13.34 %) |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | M | 18.85 | 1,000 | 18,850 | 11,800 | |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Sell | S | 43.07 | 1,000 | 43,073 | 22,705 | 23.7 K to 22.7 K (-4.22 %) |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Buy | M | 18.85 | 1,000 | 18,850 | 23,705 | 22.7 K to 23.7 K (+4.40 %) |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 43.05 | 10,000 | 430,500 | 1,697,754 | 1.7 M to 1.7 M (-0.59 %) |
| Oct 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 43.32 | 3,846 | 166,603 | 1,707,754 | 1.7 M to 1.7 M (-0.22 %) |
| Sep 22 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 45.50 | 10,000 | 454,963 | 880,206 | 890.2 K to 880.2 K (-1.12 %) |
| Sep 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 45.10 | 3,846 | 173,460 | 1,711,600 | 1.7 M to 1.7 M (-0.22 %) |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Option Exercise | M | 5.73 | 3,000 | 17,190 | 8,875 | |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Sell | S | 44.32 | 3,000 | 132,954 | 13,124 | 16.1 K to 13.1 K (-18.61 %) |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | Stetsko Gregg | VP Operations | Buy | M | 5.73 | 3,000 | 17,190 | 16,124 | 13.1 K to 16.1 K (+22.86 %) |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 11.13 | 923 | 10,268 | 3,764 | |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 9.88 | 1,077 | 10,635 | 0 | |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 44.35 | 923 | 40,936 | 22,594 | 23.5 K to 22.6 K (-3.92 %) |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 11.13 | 923 | 10,268 | 23,517 | 22.6 K to 23.5 K (+4.09 %) |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 44.35 | 1,077 | 47,766 | 22,594 | 23.7 K to 22.6 K (-4.55 %) |
| Sep 18 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 9.88 | 1,077 | 10,635 | 23,671 | 22.6 K to 23.7 K (+4.77 %) |
| Sep 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 44.25 | 2,111 | 93,412 | 11,296 | 13.4 K to 11.3 K (-15.75 %) |
| Sep 07 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 46.06 | 10,000 | 460,576 | 890,065 | 900.1 K to 890.1 K (-1.11 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.73 | 500 | 2,865 | 7,000 | |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 1,500 | 8,385 | 0 | |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 45.21 | 500 | 22,605 | 19,493 | 20 K to 19.5 K (-2.50 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.73 | 500 | 2,865 | 19,993 | 19.5 K to 20 K (+2.57 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 45.21 | 1,500 | 67,815 | 19,493 | 21 K to 19.5 K (-7.15 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 1,500 | 8,385 | 20,993 | 19.5 K to 21 K (+7.70 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 12.00 | 5,000 | 60,000 | 7,907 | |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 46.14 | 5,000 | 230,686 | 118,034 | 123 K to 118 K (-4.06 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 12.00 | 5,000 | 60,000 | 123,034 | 118 K to 123 K (+4.24 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | M | 18.85 | 1,500 | 28,275 | 12,800 | |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Sell | S | 45.21 | 1,500 | 67,815 | 21,793 | 23.3 K to 21.8 K (-6.44 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Buy | M | 18.85 | 1,500 | 28,275 | 23,293 | 21.8 K to 23.3 K (+6.88 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 11.13 | 1,000 | 11,125 | 9,313 | |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 5.73 | 1,000 | 5,730 | 19,273 | |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 5.73 | 1,000 | 5,730 | 20,273 | |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 5.73 | 2,000 | 11,460 | 21,273 | |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 46.24 | 1,000 | 46,236 | 13,993 | 15 K to 14 K (-6.67 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 5.73 | 1,000 | 5,730 | 14,993 | 14 K to 15 K (+7.15 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 45.20 | 1,000 | 45,200 | 13,993 | 15 K to 14 K (-6.67 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 5.73 | 1,000 | 5,730 | 14,993 | 14 K to 15 K (+7.15 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 46.13 | 2,000 | 92,269 | 13,993 | 16 K to 14 K (-12.51 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 5.73 | 2,000 | 11,460 | 15,993 | 14 K to 16 K (+14.29 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 46.19 | 1,000 | 46,192 | 13,993 | 15 K to 14 K (-6.67 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 11.13 | 1,000 | 11,125 | 14,993 | 14 K to 15 K (+7.15 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 46.48 | 3,846 | 178,775 | 1,715,446 | 1.7 M to 1.7 M (-0.22 %) |
| Sep 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 46.10 | 10,000 | 460,975 | 1,719,292 | 1.7 M to 1.7 M (-0.58 %) |
| Aug 29 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 45.96 | 3,846 | 176,767 | 1,729,292 | 1.7 M to 1.7 M (-0.22 %) |
| Aug 29 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 45.33 | 10,000 | 453,323 | 900,065 | 910.1 K to 900.1 K (-1.10 %) |
| Aug 22 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 46.11 | 3,846 | 177,324 | 1,733,138 | 1.7 M to 1.7 M (-0.22 %) |
| Aug 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 9.88 | 2,000 | 19,750 | 1,077 | |
| Aug 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 41.76 | 2,000 | 83,520 | 21,788 | 23.8 K to 21.8 K (-8.41 %) |
| Aug 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 9.88 | 2,000 | 19,750 | 23,788 | 21.8 K to 23.8 K (+9.18 %) |
| Aug 15 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 41.56 | 3,846 | 159,851 | 1,736,984 | 1.7 M to 1.7 M (-0.22 %) |
| Aug 11 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 41.18 | 10,000 | 411,787 | 910,065 | 920.1 K to 910.1 K (-1.09 %) |
| Aug 11 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRYSON VAUGHN D | Director | Option Exercise | X | 16.23 | 12,000 | 194,760 | 0 | |
| Aug 11 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRYSON VAUGHN D | Director | Buy | X | 16.23 | 12,000 | 194,760 | 35,000 | 23 K to 35 K (+52.17 %) |
| Aug 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 3.28 | 5,000 | 16,405 | 18,137 | |
| Aug 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 12.00 | 7,093 | 85,116 | 0 | |
| Aug 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 12.00 | 7,093 | 85,116 | 118,034 | 110.9 K to 118 K (+6.39 %) |
| Aug 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Sell | S | 46.93 | 5,000 | 234,640 | 110,941 | 115.9 K to 110.9 K (-4.31 %) |
| Aug 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 3.28 | 5,000 | 16,405 | 115,941 | 110.9 K to 115.9 K (+4.51 %) |
| Aug 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 47.41 | 3,000 | 142,230 | 13,407 | 16.4 K to 13.4 K (-18.28 %) |
| Aug 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 7.19 | 1,000 | 7,188 | 3,184 | |
| Aug 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 47.41 | 1,000 | 47,410 | 13,993 | 15 K to 14 K (-6.67 %) |
| Aug 08 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 7.19 | 1,000 | 7,188 | 14,993 | 14 K to 15 K (+7.15 %) |
| Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 1,500 | |
| Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 47.43 | 2,000 | 94,864 | 19,493 | 21.5 K to 19.5 K (-9.31 %) |
| Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 21,493 | 19.5 K to 21.5 K (+10.26 %) |
| Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | M | 18.85 | 1,500 | 28,275 | 14,300 | |
| Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Sell | S | 47.42 | 1,500 | 71,137 | 21,793 | 23.3 K to 21.8 K (-6.44 %) |
| Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Buy | M | 18.85 | 1,500 | 28,275 | 23,293 | 21.8 K to 23.3 K (+6.88 %) |
| Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 5.73 | 3,000 | 17,190 | 23,273 | |
| Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 48.28 | 3,000 | 144,840 | 13,993 | 17 K to 14 K (-17.65 %) |
| Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 5.73 | 3,000 | 17,190 | 16,993 | 14 K to 17 K (+21.44 %) |
| Aug 03 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 47.74 | 10,000 | 477,360 | 1,740,830 | 1.8 M to 1.7 M (-0.57 %) |
| Aug 01 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 48.23 | 3,846 | 185,491 | 1,750,830 | 1.8 M to 1.8 M (-0.22 %) |
| Jul 26 2006 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 202 | 0 | 4,655 | |
| Jul 26 2006 | AMLN | AMYLIN PHARMACEUTI ... | TESTMAN THOMAS R | Director | Option Exercise | A | 0.00 | 176 | 0 | 5,526 | |
| Jul 26 2006 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | A | 0.00 | 176 | 0 | 3,499 | |
| Jul 26 2006 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | A | 0.00 | 151 | 0 | 3,350 | |
| Jul 26 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 0.00 | 151 | 0 | 4,023 | |
| Jul 26 2006 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 0.00 | 252 | 0 | 908 | |
| Jul 26 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRYSON VAUGHN D | Director | Option Exercise | A | 0.00 | 202 | 0 | 4,911 | |
| Jul 26 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 48.65 | 10,000 | 486,462 | 920,065 | 930.1 K to 920.1 K (-1.08 %) |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 48.02 | 3,846 | 184,698 | 1,754,676 | 1.8 M to 1.8 M (-0.22 %) |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 267 | 3,538 | 0 | |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 9.88 | 1,733 | 17,113 | 3,077 | |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 48.38 | 1,733 | 83,847 | 21,788 | 23.5 K to 21.8 K (-7.37 %) |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 9.88 | 1,733 | 17,113 | 23,521 | 21.8 K to 23.5 K (+7.95 %) |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 48.38 | 267 | 12,918 | 21,788 | 22.1 K to 21.8 K (-1.21 %) |
| Jul 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 267 | 3,538 | 22,055 | 21.8 K to 22.1 K (+1.23 %) |
| Jul 14 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 48.62 | 10,000 | 486,233 | 930,065 | 940.1 K to 930.1 K (-1.06 %) |
| Jul 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Sell | S | 50.00 | 7,000 | 350,013 | 32,000 | 39 K to 32 K (-17.95 %) |
| Jul 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Sell | S | 50.00 | 500 | 25,001 | 7,000 | 7.5 K to 7 K (-6.67 %) |
| Jul 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 50.00 | 500 | 25,000 | 16,407 | 16.9 K to 16.4 K (-2.96 %) |
| Jul 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 49.77 | 3,000 | 149,297 | 16,907 | 19.9 K to 16.9 K (-15.07 %) |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 48.00 | 10,000 | 479,951 | 1,758,522 | 1.8 M to 1.8 M (-0.57 %) |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 48.82 | 3,846 | 187,774 | 1,768,522 | 1.8 M to 1.8 M (-0.22 %) |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 3,500 | |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 48.02 | 2,000 | 96,041 | 19,493 | 21.5 K to 19.5 K (-9.31 %) |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 21,493 | 19.5 K to 21.5 K (+10.26 %) |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | M | 18.85 | 1,500 | 28,275 | 15,800 | |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Sell | S | 48.01 | 1,500 | 72,017 | 21,793 | 23.3 K to 21.8 K (-6.44 %) |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Buy | M | 18.85 | 1,500 | 28,275 | 23,293 | 21.8 K to 23.3 K (+6.88 %) |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 9.63 | 500 | 4,813 | 4,500 | |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Option Exercise | M | 9.63 | 2,500 | 24,063 | 5,000 | |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 48.86 | 500 | 24,430 | 13,993 | 14.5 K to 14 K (-3.45 %) |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 9.63 | 500 | 4,813 | 14,493 | 14 K to 14.5 K (+3.57 %) |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Sell | S | 48.86 | 2,500 | 122,150 | 13,993 | 16.5 K to 14 K (-15.16 %) |
| Jul 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BARON ALAIN D | Sr VP Research | Buy | M | 9.63 | 2,500 | 24,063 | 16,493 | 14 K to 16.5 K (+17.87 %) |
| Jun 30 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 5,500 | |
| Jun 30 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 19,493 | 17.5 K to 19.5 K (+11.43 %) |
| Jun 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 43.07 | 3,846 | 165,645 | 1,772,368 | 1.8 M to 1.8 M (-0.22 %) |
| Jun 30 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 47.02 | 10,000 | 470,182 | 940,065 | 950.1 K to 940.1 K (-1.05 %) |
| Jun 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Option Exercise | M | 13.25 | 2,000 | 26,500 | 267 | |
| Jun 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Sell | S | 43.00 | 2,000 | 86,000 | 21,788 | 23.8 K to 21.8 K (-8.41 %) |
| Jun 19 2006 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Senior VP, Finance ... | Buy | M | 13.25 | 2,000 | 26,500 | 23,788 | 21.8 K to 23.8 K (+9.18 %) |
| Jun 14 2006 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 42.41 | 10,000 | 424,100 | 950,065 | 960.1 K to 950.1 K (-1.04 %) |
| Jun 14 2006 | AMLN | AMYLIN PHARMACEUTI ... | ALTMAN STEVEN R | Director | Grant | A | 43.11 | 6,900 | 297,433 | 13,455 | 6.6 K to 13.5 K (+105.26 %) |
| Jun 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 7,500 | |
| Jun 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Buy | M | 5.59 | 2,000 | 11,180 | 17,493 | 15.5 K to 17.5 K (+12.91 %) |
| Jun 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | President and Chief ... | Option Exercise | M | 23.00 | 10,868 | 249,964 | 6,520 | |
| Jun 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | President and Chief ... | Option Exercise | M | 16.54 | 1 | 17 | 6,163 | |
| Jun 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | President and Chief ... | Buy | M | 16.54 | 1 | 17 | 141,496 | 141.5 K to 141.5 K (0.00 %) |
| Jun 12 2006 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | President and Chief ... | Buy | M | 23.00 | 10,868 | 249,964 | 141,495 | 130.6 K to 141.5 K (+8.32 %) |
| Jun 07 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 44.45 | 235 | 10,446 | 19,907 | 20.1 K to 19.9 K (-1.17 %) |
| Jun 07 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 44.75 | 765 | 34,234 | 20,142 | 20.9 K to 20.1 K (-3.66 %) |
| Jun 07 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 45.00 | 1,000 | 45,000 | 20,907 | 21.9 K to 20.9 K (-4.56 %) |
| Jun 07 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Sell | S | 45.50 | 1,000 | 45,500 | 21,907 | 22.9 K to 21.9 K (-4.37 %) |
| Jun 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 46.74 | 3,846 | 179,777 | 1,776,214 | 1.8 M to 1.8 M (-0.22 %) |
| Jun 06 2006 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | Chief Operating Off ... | Option Exercise | A | 47.73 | 30,000 | 1,431,900 | 30,000 | |
| Jun 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Sell | S | 44.90 | 10,000 | 448,989 | 1,780,060 | 1.8 M to 1.8 M (-0.56 %) |
| Jun 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Option Exercise | M | 5.59 | 2,000 | 11,180 | 9,500 | |
| Jun 02 2006 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Legal & General ... | Sell | S | 45.57 | 2,000 | 91,140 | 15,493 | 17.5 K to 15.5 K (-11.43 %) |